Akebia Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Akebia Therapeutics, Inc. Website Screenshot

http://www.akebia.com

Akebia Therapeutics, Inc. Company Intro

Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.

Industry

Healthcare

Akebia Therapeutics, Inc. Headquaters

245 First Street
Cambridge,02142
United States


Akebia Therapeutics, Inc. Share price

26 Oct 2020 01:03 GMT

$3.3442

0.06 (1.96 %)


Akebia Therapeutics, Inc. Market cap

$455.748 M


WMC RANKING

2020

Akebia Therapeutics, Inc. # 20

Biotechnology



Latest Akebia Therapeutics, Inc. News

News 25 Oct 2020

Iron Deficiency Anemia Therapy Market 2020 Segmentation ...

... Akebia Therapeutics; AMAG Pharmaceuticals; Keryx Biopharmaceuticals Inc. Luitpold Pharmaceuticals Inc. Johnson & Johnson; Pharmacosmos AS; Pieris ...

News 26 Oct 2020

Think You Need A Good Stock? Look At This Akebia Therapeutics, Inc. (NASDAQ:AKBA) Analysis

Akebia Therapeutics, Inc. (NASDAQ:AKBA) traded at $3.18 at last check on Friday, Oct ... The company's stock has gained about 29.27% over that past 30 days.

News 26 Oct 2020

Akebia Therapeutics Inc. (AKBA) and ZIOPHARM Oncology Inc. (ZIOP) Have A Decent Quarter, Future Looks Brighter

SIMPLEX TRADING LLC bought a fresh place in Akebia Therapeutics Inc. (NASDAQ:AKBA). The institutional investor bought 52.8 thousand shares of the stock ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Akebia Therapeutics, Inc. 5.88 1.87 12.02 0 0 0 10.41
Alexion Pharmaceuticals, Inc. 100 13.29 100 20 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.09 26 0 0 97.35
3SBio Inc. 96.05 0 0 4 0 0 2.78
Incyte Corporation 40.27 14.26 7.21 100 0 0 90.91

Akebia Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Akebia Therapeutics, Inc. $325,296 $491,894 $-245,230 $455.748M 20
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.654B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.11B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.42B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.615B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Akebia Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Akebia Therapeutics, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries